Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
213 studies found for:    Open Studies | "Mycoses"
Show Display Options
Rank Status Study
21 Recruiting Fungiscope - A Global Emerging Fungal Infection Registry
Condition: Invasive Fungal Disease
Intervention:
22 Unknown  Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections
Conditions: Fungal Infections;   Tinea Pedis;   Tinea Cruris;   Tinea Corporis
Intervention: Drug: Clotrimazole
23 Unknown  Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT
Conditions: Invasive Fungal Infection;   Aspergillosis;   Fungemia;   Hematopoietic Stem Cell Transplantation
Intervention:
24 Recruiting Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With MF With Variable CD30 Expression Level
Conditions: Lymphoma, Non-Hodgkin;   Cutaneous Lymphoma;   Cutaneous T Cell Lymphoma;   Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: Brentuximab vedotin
25 Recruiting Studies of Disorders With Increased Susceptibility to Fungal Infections
Conditions: Primary Immune Deficiency;   Candida;   Autoimmune Polyendocrinopathy Candidiasis Ectodermal;   Chronic Mucocutaneous Candidiasis (CMC);   Fungal Infection
Intervention:
26 Unknown  Registry of Febrile Neutropenia and Invasive Fungal Infections
Conditions: Hematological Disease;   Febrile Neutropenia;   Fungal Infections
Intervention: Other: Patient registry
27 Recruiting Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
Conditions: Neutropenia;   Fungal Disease
Intervention: Drug: micafungin
28 Recruiting Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Conditions: Fungal Infection;   Hematopoietic/Lymphoid Cancer
Interventions: Drug: caspofungin acetate;   Drug: fluconazole;   Drug: voriconazole;   Other: laboratory biomarker analysis
29 Recruiting Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Minimally Differentiated Myeloid Leukemia (M0);   Adult Acute Monoblastic Leukemia (M5a);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Myelomonocytic Leukemia (M4);   Adult Erythroleukemia (M6a);   Adult Pure Erythroid Leukemia (M6b);   Childhood Acute Erythroleukemia (M6);   Childhood Acute Megakaryocytic Leukemia (M7);   Childhood Acute Minimally Differentiated Myeloid Leukemia (M0);   Childhood Acute Monoblastic Leukemia (M5a);   Childhood Acute Monocytic Leukemia (M5b);   Childhood Acute Myeloblastic Leukemia With Maturation (M2);   Childhood Acute Myeloblastic Leukemia Without Maturation (M1);   Childhood Acute Myeloid Leukemia in Remission;   Childhood Acute Myelomonocytic Leukemia (M4);   Fungal Infection;   Neutropenia;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Secondary Acute Myeloid Leukemia;   Untreated Adult Acute Myeloid Leukemia;   Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Interventions: Drug: caspofungin acetate;   Drug: fluconazole;   Other: laboratory biomarker analysis
30 Unknown  Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
Conditions: Neutropenia;   Hematopoietic Stem Cell Transplantation;   Invasive Fungal Disease
Intervention: Drug: Micafungin
31 Recruiting Dasatinib in Treating Patients With Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma Previously Treated With Autologous Stem Cell Transplant
Conditions: Non-Hodgkin's Lymphoma;   Multiple;   Mycosis Fungoides;   Hodgkin's Lymphoma;   Multiple Myeloma
Intervention: Drug: Dasatinib
32 Recruiting Blood and Tissue Collection for Cutaneous Lymphoma Research
Conditions: Cutaneous T-cell Lymphoma;   Sezary Syndrome;   Mycosis Fungoides
Intervention: Other: Blood draw or skin biopsy
33 Not yet recruiting Effectiveness of Imiquimod 3.75% Topical Cream Compared to Vanos Cream 0.1% in Subjects With Early Stage Cutaneous T-cell Lymphoma
Condition: Mycosis Fungoides
Interventions: Drug: 3.75% Imiquimod Cream;   Drug: 0.1% Fluocinonide Cream
34 Unknown  Effect of Denileukin Diftitox on Immune System in CTCL Patients
Conditions: Cutaneous T-Cell Lymphoma;   Sezary Syndrome;   Mycosis Fungoides
Intervention:
35 Recruiting Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas
Conditions: Lymphoma, T-Cell, Cutaneous;   Mycosis Fungoides
Interventions: Drug: Methotrexate;   Drug: Interferon Alfa-2b
36 Not yet recruiting Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
Conditions: Cutaneous T-cell Lymphoma;   Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: Doxycycline monohydrate
37 Unknown  Prophylaxis With Caspofungin in High-Risk Liver Transplantation
Conditions: Liver Transplantation;   Fungal Infection
Intervention: Drug: Caspofungin
38 Recruiting A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)
Conditions: T-cell Lymphomas;   T-cell Leukemia;   Sezary Syndrome;   Mycosis Fungoides;   Cutaneous T-cell Lymphoma (CTCL)
Intervention: Biological: A-dmDT390-bisFv(UCHT1)
39 Recruiting A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma
Conditions: Primary Cutaneous Anaplastic Large Cell Lymphoma,;   Mycosis Fungoides;   Cutaneous T-Cell Lymphoma
Interventions: Drug: Brentuximab Vedotin;   Drug: Methotrexate or Bexarotene
40 Unknown  T Cell Repertoire Analysis of Immune Mediated Skin Diseases
Conditions: Psoriasis;   Mycosis Fungoides
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years